The Leadership Team at Mirati Therapeutics is responsible for guiding the strategic direction of the company while fostering innovation in cancer therapies. This diverse group oversees operations, clinical development, drug discovery, compliance, and business development, ensuring collaboration across departments to accelerate the discovery and delivery of impactful treatments for patients. Their combined expertise drives the company’s mission to transform patient lives through groundbreaking science and operational excellence.
David Rubin
Vice President, Intellectual P...
Denise Hanly Bruns
Senior Vice President, Integra...
Hirak der-Torossian ...
Vice President Clinical Develo...
James Christensen
EVP, Chief Scientific Officer
Jessica Corson
VP, Business Development
Peter Lee
Chief Compliance Officer
Sanjeev Sharma
Senior Vice President
Susan Welsh
Chief Safety Officer
Thian Kheoh
VP, Biometrics
Todd Baumgartner
Senior Principal Scientist
View all